Marthe Fourcade's profile photo

Marthe Fourcade

Paris

Editor at Bloomberg News

Featured in: Favicon bloomberg.com Favicon msn.com Favicon indiatimes.com Favicon independent.co.uk Favicon time.com Favicon yahoo.com (+3) Favicon latimes.com Favicon nydailynews.com Favicon sfgate.com Favicon smh.com.au

Articles

  • 1 month ago | news.bloombergtax.com | Marthe Fourcade

    XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

  • 1 month ago | bloomberg.com | Marthe Fourcade

    Honeywell branding. (Bloomberg) -- Johnson Matthey Plc shares soared by more than a third after announcing the sale of its catalyst business to Honeywell International Inc. for an enterprise value of about £1.8 billion ($2.4 billion) in cash. The stock climbed as much as 34% in early London trading. The gain added about £760 million to the company’s market value, taking it to about £3.1 billion. Johnson Matthey announced the Honeywell deal on Thursday amid an effort to streamline its business.

  • 2 months ago | rs.bloombergadria.com | Marthe Fourcade

    Podeli vest WhatsApp Viber Link copied Copy link Kompanije 22. april 2025, 14:13 Akcije Novo Nordiska pale su zbog straha investitora da bi nova pilula za mršavljenje, koju razvija Eli Lilly, mogla da preotme deo tržišta popularnim injekcionim lekovima poput "ozempica".

  • 2 months ago | fortune.com | Marthe Fourcade

    David Ricks, chief executive officer of Eli Lilly & Co.Annabelle Gordon/Bloomberg via Getty Images

  • 2 months ago | bloomberg.com | Marthe Fourcade

    Novo Nordisk signage in Bagsvaerd, Denmark. Photographer: Mads Claus Rasmussen/Getty Images(Bloomberg) -- Novo Nordisk A/S slumped amid concern that a weight-loss pill from rival Eli Lilly & Co. will steal market share from bestsellers such as its injected blockbuster Ozempic. The stock dropped as much as 9.8% to 380 kroner on the first trading day since Lilly said that an experimental pill helped patients shed weight and control blood sugar about as well as Ozempic.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
68
Tweets
7
DMs Open
No
Marthe Fourcade
Marthe Fourcade @MartheFourcade
19 Jun 23

Here's how AI is powering the yogurt revolution #AI #yogurt

Dasha Afanasieva
Dasha Afanasieva @dasha_reports

I wrote 1,600 words on ... yogurt... and @MartheFourcade edited them Danone is pinning its hopes on AI to create the yogurt of the future — and revive its business #guthealth https://t.co/NlIBwstQUd via @business

Marthe Fourcade
Marthe Fourcade @MartheFourcade
16 Dec 22

For your weekend read: how villages in #NewZealand #France #Netherlands are empowering people with #Alzheimers and developing new models of #dementiacare. Urgent when people living with Alzheimer's may nearly triple by 2050. #dementia https://t.co/0jc37dLwZ9 via @BW

Marthe Fourcade
Marthe Fourcade @MartheFourcade
13 Dec 22

Living Well With Alzheimer’s Thanks to a Village Square, Two Donkeys and Autonomy https://t.co/0jc37dLwZ9 via @BW